Tiffany, Kors to Re...
Health Care: Drugs
Cyclacel Pharmaceuticals Inc. (CYCC: NASDAQ)
$3.25 0.07 | 2.20%
05/24/13 - 04:00 PM ET
Company Cash Flow
| Dec 2012 | Dec 2011 | Dec 2010 | Dec 2009 | |
| Cash Flow From Operating Activities | ||||
|---|---|---|---|---|
| Net Income (Loss) | -13.19M | -15.24M | -16.02M | -19.57M |
| Operating Gains/Losses | -62.00K | 1.00K | -13.00K | 83.00K |
| Extraordinary Gains / Losses | 0.00 | 0.00 | 0.00 | 0.00 |
| (Increase) Decrease In Receivables | 0.00 | 0.00 | 0.00 | 0.00 |
| (Increase) Decrease in Inventories | 0.00 | 0.00 | 0.00 | 0.00 |
| (Increase) Decrease In Other Current Assets | 0.00 | 0.00 | 0.00 | 0.00 |
| (Decrease) Increase In Payables | 1.77M | 577.00K | -3.07M | 514.00K |
| (Decrease) Increase In Other Current Liabilities | 0.00 | 0.00 | 0.00 | 0.00 |
| (Increase) Decrease In Other Working Capital | 0.00 | 0.00 | 0.00 | 0.00 |
| Other Non-Cash Items | -384.00K | 273.00K | 2.08M | 1.37M |
| Net Cash From Continuing Operations | -12.04M | -13.98M | -16.04M | -15.19M |
| Net Cash From Discontinued Operations | 0.00 | 0.00 | 0.00 | 0.00 |
| Cash Provided By Investing Activities | ||||
| Net Cash From Total Operating Activities | -12.04M | -13.98M | -16.04M | -15.19M |
| Sale of Property, Plant & Equipment | 62.00K | 5.00K | 41.00K | 91.00K |
| Cash Used for Investing Activities | ||||
| Sale of Short-Term Investments | 0.00 | 0.00 | 0.00 | 1.48M |
| Purchases of Property, Plant & Equipment | -12.00K | -6.00K | -8.00K | -15.00K |
| Acquisitions | 0.00 | 0.00 | 0.00 | 0.00 |
| Purchases of Short-Term Investments | 0.00 | 0.00 | 0.00 | 0.00 |
| Other Cash from Investing Activities | 0.00 | 0.00 | 0.00 | 0.00 |
| Cash Provided by Financing Activities | ||||
| Net Cash From Investing Activities | 50.00K | -1.00K | 33.00K | 1.56M |
| Issuance of Debt | 0.00 | 0.00 | 0.00 | 0.00 |
| Cash Used for Financing Activities | ||||
| Issuance of Capital Stock | 94.00K | 3.00K | 33.40M | 3.85M |
| Repayment of Long-Term Debt | 0.00 | 0.00 | 0.00 | 0.00 |
| Repurchase of Capital Stock | 0.00 | 0.00 | 0.00 | 0.00 |
| Payment of Cash Dividends | 0.00 | -364.00K | 0.00 | 0.00 |
| Other Financing Charges, Net | 3.88M | 9.27M | 0.00 | 0.00 |
| Net Cash From Financing Activities | 3.98M | 8.91M | 33.40M | 3.85M |
| Effect of Exchange Rate Changes | -19.00K | 26.00K | 617.00K | -2.94M |
| Net Change in Cash & Cash Equivalents | -8.04M | -5.05M | 18.00M | -12.73M |
Portfolios with CYCC
- Portfolio NameUser Type
- ContributorEarnings Short Squeeze Play...
- ContributorStocks Under-$10 Moving Hig...
- ContributorBreakout Stocks Of The Week...
- ContributorStocks Under-$10 Moving Hig...
- ContributorStocks Under-$10 Moving Hig...
- Uservlady 1
- Contributor13 Biotech Stocks Bought an...
- ProWilbur Ross - Invesco Priva...
- Contributor10 Cheap Biotech Stocks Tha...
- Userjeezlola
Latest CYCC Headlines from TheStreet
- Cyclacel Pharmaceuticals Announces Closing Of Underwritten Offering 05.21.13 | 04:05 pm
- Cyclacel Pharmaceuticals Announces $20 Million Underwritten Offering 05.16.13 | 09:05 am
- Cyclacel Pharmaceuticals Announces Proposed Public Offering Of Common Stock 05.15.13 | 04:05 pm
- Cyclacel Reports First Quarter 2013 Financial Results 05.13.13 | 04:05 pm
- Cyclacel Pharmaceuticals To Announce Release Of First Quarter 2013 Financial Results 05.10.13 | 07:05 am
- Cyclacel Reports Updated Phase 2 Survival Data Of Sapacitabine For MDS 04.30.13 | 07:04 am
- Cyclacel Pharmaceuticals To Present At The 12th Annual Needham Healthcare Conference 04.23.13 | 07:04 am
- Reminder: Cyclacel Pharmaceuticals' 6% Preferred Stock Goes Ex-Dividend Soon 04.16.13 | 01:04 pm
- Combination Potential Of Cyclacel's Sapacitabine And Seliciclib Reported At AACR 04.09.13 | 02:04 pm
- AACR Press Conference Highlights Combination Potential Of Two Cyclacel Drugs 04.08.13 | 07:04 am
Press Releases for CYCC
Partner Headlines for CYCC
- Cyclacel Pharma to Offer New Sapacitabine Data at ASH on Dec. 9th - Benzinga 12.04.12 | 09:12 am
- Upcoming AML Treatments - Which Company Will Fly? - Seeking Alpha 12.03.12 | 09:12 am
- 4 Cash Loaded Biotech Stocks With Little Debt - Seeking Alpha 08.30.12 | 09:08 am
- Biotechnology Stocks To Watch Ahead Of ASCO 2012: Part 3 - Seeking Alpha 05.25.12 | 08:05 pm
- Cyclacel: An Intriguing Long Shot - Seeking Alpha 03.20.12 | 08:03 am
- Q3 Micro-Cap Biotech Picks By The World's Largest Fund Managers - Seeking Alpha 12.08.11 | 09:12 am
- Zacks #1 Rank Additions for Friday - Tale of the Tape - Zacks 11.18.11 | 09:11 am
- Buy And Sell Ideas Based On Wednesday's Big News And Price Decliners - Seeking Alpha 09.29.11 | 08:09 am
- The Biotech Bump: Cyclacel Pharmaceuticals - Benzinga 07.28.11 | 01:07 pm
- Profit From These 3 Analysts' Stock Picks for Under $10 - Seeking Alpha 07.13.11 | 09:07 am
